Sale of 25,817 shares at $209.2497 per share.
Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code S
Traded Aug 21, 2026 · Disclosed Aug 25, 2026
Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Revolution Medicines, Inc. (RVMD)." Disclosed 2026-08-25. https://desqlong.com/cards/0001610717-26-000388-5 (retrieved 2026-09-26).